Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
ALXO: ALX Oncology Holdings Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
ALXO
The Story
ALXO
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
0.0%
ROIC
-55.8%
Financially safe
Stretched
Debt / equity
0.03×
Interest coverage
-59.7×
Current ratio
7.21×
ALX Oncology Holdings Inc.
ALXO
NASDAQ
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
ALX Oncology Holdings Inc.
ALXO
NASDAQ
·
USD
·
Closed
$1.94
−0.51%
$1.94
−$0.01 (0.51%)
52W Range
67th
pctl
Volume
0.50×
avg
Mkt Cap
261.05M
USD
P/E
-1.2
TTM
Div Yield
–
ann
52W Range
67th
pctl
Volume
0.50×
avg
Market Cap
261.05M
USD
P/E Ratio
-1.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings